Topoisomerase I inhibitor and thymidylate synthase inhibitor

This page covers all Topoisomerase I inhibitor and thymidylate synthase inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Topoisomerase I and thymidylate synthase.

Targets

Topoisomerase I and thymidylate synthase

Phase 3 pipeline (1)

• capecitabine-irinotecan · Dutch Colorectal Cancer Group · Oncology
  Capecitabine-irinotecan combines a prodrug of fluorouracil with a topoisomerase I inhibitor to target rapidly dividing cancer cells.

Patent intelligence

• topoisomerase i inhibitor and thymidylate synthase inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates